Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole

Completed · Phase 1

Conditions studied: Alzheimer Disease

In brief

The purpose of the study is to determine if the concomitant administration of either ketoconazole or fluconazole with BMS-708163 will affect the PK of BMS-708163 and to assess safety and tolerability of BMS-708163

Key facts

Study ID

NCT00860275

Run by

Bristol-Myers Squibb

People needed

30

Starts

2009-04-01

Expected to finish

2009-06-01

Last updated by the study team

2011-01-25

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and postmenopausal female subjects 18-55 yrs old inclusive
• Exclusion:
• Premenopausal women

Where it is running

• Ppd Development, Lp — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.